Product Images Bidil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Bidil NDC 24338-010 by Azurity, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text describes a Kaplan-Meier plot of Time to Death by All Cause in Black Patients (A-HeFT). The plot show data points for Placebo and also mentions a Log-Rank Test. The axis shows the Time (Days) and the number of patients who are alive. The text also shows some numeric values for Placebo.*
This is a Kaplan-Meier plot of time to the first hospitalization for heart failure in black patients using BiDil compared to placebo, showing a 39% risk reduction in the first hospitalization for heart failure. The x-axis represents the time in days, while the y-axis shows the percent of patients without hospitalization. The plot demonstrates that BiDil reduces the risk of heart failure hospitalization significantly compared to the placebo group.*
The figure shows the change in Minnesota Living score with Heart Failure. Unfortunately, the rest of the text is not-readable or garbled.*
This is a description of a medication called BiDil. The medication comes as 90 tablets in a bottle with an NDC code of 24338-010-09. The tablets contain a combination of isosorbide dinitrate and hydralazine hydrochloride (20mg and 3765mg, respectively). The medication should be stored at room temperature between 15°C - 30°C (59°F - 86°F). The rest of the text seems to be unreadable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.